Sylvia Wagner

2.4k citations

47 papers · 1.9k indexed · h-index 21

Impact in

Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems

Papers in

Pharmaceutical Science 6
- Advanced Drug Delivery Systems 4
Biomaterials 11
- Nanoparticle-Based Drug Delivery 10

Co-authors: Hagen von Briesen Jörg Kreuter Klaus Langer Claudia Büchel Franz Worek Sascha Wien Larisa Mihoreanu David J. Begley
Journals: PLoS ONE (4 papers)Pharmaceutics (3 papers)Acta Ophthalmologica (2 papers)European Journal of Pharmaceutical Sciences (2 papers)Journal of Drug Delivery Science and Technology (2 papers)
Partner nations: Germany United States Austria

In The Last Decade

Sylvia Wagner

46 papers receiving 1.8k citations

Peers

Countries citing papers authored by Sylvia Wagner

Since Specialization

Citations

This map shows the geographic impact of Sylvia Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Wagner more than expected).

Fields of papers citing papers by Sylvia Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Wagner. The network helps show where Sylvia Wagner may publish in the future.

Co-authors

The 25 scholars most cited alongside Sylvia Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sylvia Wagner Line = papers co-authored together Sylvia Wagner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of an inhalable dry powder formulation for inhibition of SARS-CoV-2 International Journal of Pharmaceutics X ·Rana Bahij, Anja Germann, 紀三郎西村, Sylvia Wagner, Marc Schneider	2025	1
2	Evaluation of the Transport and Binding of Dopamine-Loaded PLGA Nanoparticles for the Treatment of Parkinson’s Disease Using In Vitro Model Systems Pharmaceutics ·RT D'Agnolo, Saul D. Rivas, Marcus Koch, Li-Jing Ren, Yingqi Fang, Pueschel Sm, Johannes Krämer, Annette Kraegeloh, Sylvia Wagner	2024	3
3	Ex vivo models for intestinal translocation studies of cellulose nanocrystals PubMed ·浩二久保田, Roland Drexel, Gustavo Samuel de Moura Serpa, Stephan Dähnhardt‐Pfeiffer, M.V. Rylnikova, Christine Herrmann, Rodrigo L. Dias, Antônio D. Pandolfi Filho, Heiko Briesen, Sylvia Wagner, Florian Meier, Yvonne Kohl	2023	1
4	Alveolar epithelial-like cell differentiation in a dynamic bioreactor: a promising 3D-approach for the high-throughput generation of lung cell types from human induced pluripotent stem cells PubMed ·浩二久保田, Yvonne Kohl, Anja Germann, Sylvia Wagner, Heiko Zimmermann, Hagen von Briesen	2023	0
5	Electrospun Scaffolds as Cell Culture Substrates for the Cultivation of an In Vitro Blood–Brain Barrier Model Using Human Induced Pluripotent Stem Cells Pharmaceutics ·Nisreen M. Rahmah, RT D'Agnolo, Merit D. Lemke, Sylvia Wagner, Maike Windbergs	2022	15
6	Experimental Comparison of Primary and hiPS-Based In Vitro Blood–Brain Barrier Models for Pharmacological Research Pharmaceutics ·RT D'Agnolo, Werner Förster, Sascha Wien, M.V. Rylnikova, Hagen von Briesen, Sylvia Wagner	2022	4
7	Investigating Alkylated Prodigiosenes and Their Cu(II)‐Dependent Biological Activity: Interactions with DNA, Antimicrobial and Photoinduced Anticancer Activity ChemMedChem ·MAMrivm Jacobs-van der Bruggen, Matthew White, Virginia Harder, High Support Special Schools, Andrea T. Feßler, RT D'Agnolo, Gerhard D. Wieland, Sylvia Wagner, Štefan Schwarz, Arno Wiehe, Nora Kulak	2021	6
8	Validation of human microRNA target pathways enables evaluation of target prediction tools Nucleic Acids Research ·Fabian Kern, Gregor Kosec, RT D'Agnolo, Caroline Diener, Tim Kehl, Aashutosh Bhattad, Tobias Fehlmann, Mustafa Kahraman, Stefanie Rheinheimer, Ernesto Aparicio‐Puerta, Sylvia Wagner, Nicole Ludwig, Christina Backes, Hans‐Peter Lenhof, Hagen von Briesen, Martin Hart, Andreas Keller, Eckart Meese	2020	44
9	Die Bayer AG öffnet ehemaligen Heimkindern ihr Archiv Susan Moore Mauroux, Mulyono Mulyono, Xia Hanliang, Sylvia Wagner, Riddhi Bhalani	2020	1
10	The comet assay applied to HepG2 liver spheroids Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Elisabeth Elje, Michelle Hesler, Elise Rundén‐Pran, ΠΑΝΤΑΖΗΣ ΚΥΡΙΑΖΗΣ, Espen Mariussen, Sylvia Wagner, Mária Dušinská, Yvonne Kohl	2019	50
11	Synthesis and in vitro evaluation of cyclodextrin hyaluronic acid conjugates as a new candidate for intestinal drug carrier for steroid hormones European Journal of Pharmaceutical Sciences ·Michelle Hesler, Pereyra Bonija, Stephan Dähnhardt‐Pfeiffer, Sylvia Wagner, Hagen von Briesen, Gerhard Wenz, Yvonne Kohl	2019	12
12	Identification of Molecular Markers of Delayed Graft Function Based on the Regulation of Biological Ageing PLoS ONE ·Dagmara McGuinness, Johannes Leierer, Jiawei He, Suhaib Mohammed, D. Pedoe, David Kingsmore, Ann‐Margaret Little, Julia Kerschbaum, Stefan Schneeberger, Manuel Maglione, Silvio Nadalin, Sylvia Wagner, Alfred Königsrainer, Emma Aitken, MR Halter, Marc Clancy, Alex McConnachie, Christian Koppelstaetter, Karen Stevenson, Paul G. Shiels	2016	28
13	Quantitative bioimaging of platinum group elements in tumor spheroids Analytica Chimica Acta ·우진섭, Manfred Wirsum, 何正平, Dennis Mulac, J DHAYS, N A Holt, Rebecca Buchholz, Ursula Canton, Arno Wiehe, Sylvia Wagner, Michael Sperling, Hagen von Briesen, Klaus Langer, Uwe Kärst	2016	29
14	Tracking of Magnetite Labeled Nanoparticles in the Rat Brain Using MRI PLoS ONE ·A. Gottstein, Reinhold Schmidt, Klaus Langer, Yifan Luo, Robert Wronski, TU Zhi-pin, Daniel Havas, Manfred Windisch, Hagen von Briesen, Sylvia Wagner, Julia Stäb, Herre Hp, Claus U. Pietrzik, Franz Fazekas, Stefan Ropele	2014	8
15	Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model Alzheimer s Research & Therapy ·Deepa Patil, Yifan Luo, Julia Stäb, Dominic Docter, Sandra Baches, Roland H. Stauber, Mordechai Deutsch, Reinhold Schmidt, Stefan Ropele, Manfred Windisch, Klaus Langer, Sylvia Wagner, Hagen von Briesen, Sascha Weggen, Claus U. Pietrzik	2013	52
16	A palladium label to monitor nanoparticle-assisted drug delivery of a photosensitizer into tumor spheroids by elemental bioimaging Metallomics ·우진섭, 何正平, J DHAYS, Arno Wiehe, Dennis Mulac, Christoph A. Wehe, Olga Reifschneider, JaiRanSong, Sylvia Wagner, Michael Sperling, Hagen von Briesen, Klaus Langer, Uwe Kärst	2013	20
17	Uptake Mechanism of ApoE-Modified Nanoparticles on Brain Capillary Endothelial Cells as a Blood-Brain Barrier Model PLoS ONE ·Sylvia Wagner, Carlos-Manuel Sánchez-González, Sascha Wien, Daniela Amado Rabelo, Betsy Daniela, Tikva Vogel, Franz Worek, Claus U. Pietrzik, Jörg Kreuter, Hagen von Briesen	2012	207
18	Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells Nanomedicine Nanotechnology Biology and Medicine ·Karin Löw, Matthias G. Wacker, Sylvia Wagner, Klaus Langer, Hagen von Briesen	2011	57
19	HI 6 human serum albumin nanoparticles—Development and transport over an in vitro blood–brain barrier model Toxicology Letters ·Vidyulata Madhu, Sylvia Wagner, Sascha Wien, Oscar Abramovich, Franz Worek, Hagen von Briesen, Jörg Kreuter	2011	54
20	Adsorption of obidoxime onto human serum albumin nanoparticles: Drug loading, particle size and drug release Journal of Microencapsulation ·Oscar Abramovich, Sylvia Wagner, Franz Worek, Hagen von Briesen, Jörg Kreuter	2010	42

About Sylvia Wagner

Sylvia Wagner is a scholar working on Pharmaceutical Science, Biomaterials, Applied Microbiology and Biotechnology, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 47 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), 3D Printing in Biomedical Research (6 papers), Protein Interaction Studies and Fluorescence Analysis (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Advanced Drug Delivery Systems (4 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Barrier Structure and Function Studies (4 papers). The work is most often cited by research in Biomaterials (716 citations), Pharmaceutical Science (247 citations), Pollution (247 citations), Molecular Medicine (77 citations) and Industrial and Manufacturing Engineering (116 citations). Sylvia Wagner has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Hagen von Briesen, Jörg Kreuter, Klaus Langer, Claudia Büchel, Franz Worek, Sascha Wien, Larisa Mihoreanu, David J. Begley, Céline Legros and Yvonne Kohl. Their work appears in journals such as PLoS ONE, Pharmaceutics, Acta Ophthalmologica, European Journal of Pharmaceutical Sciences and Journal of Drug Delivery Science and Technology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact